EP1852117A4 - Agent pharmaceutique comprenant de la solifenacine - Google Patents

Agent pharmaceutique comprenant de la solifenacine

Info

Publication number: EP1852117A4
Authority: EP; European Patent Office
Prior art keywords: solifenacin; pharmaceutical agent; pharmaceutical; agent
Prior art date: 2005-02-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP06714366A

Other languages

German (de)

English (en)

Other versions

EP1852117A1 (fr

Inventor

Ken Ikeda

Shuichi Sato

Masanori Suzuki

Akiyoshi Ohtake

Yasushi Ikeda

Kenji Yasukawa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Astellas Pharma Inc

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-25

Filing date

2006-02-23

Publication date

2010-10-27

2006-02-23 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2007-11-07 Publication of EP1852117A1 publication Critical patent/EP1852117A1/fr

2010-10-27 Publication of EP1852117A4 publication Critical patent/EP1852117A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP06714366A 2005-02-25 2006-02-23 Agent pharmaceutique comprenant de la solifenacine Withdrawn EP1852117A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2005050370		2005-02-25
PCT/JP2006/303226 WO2006090759A1 (fr)	2005-02-25	2006-02-23	Agent pharmaceutique comprenant de la solifenacine

Publications (2)

Publication Number	Publication Date
EP1852117A1 EP1852117A1 (fr)	2007-11-07
EP1852117A4 true EP1852117A4 (fr)	2010-10-27

Family

ID=36927397

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP06714366A Withdrawn EP1852117A4 (fr)	2005-02-25	2006-02-23	Agent pharmaceutique comprenant de la solifenacine

Country Status (5)

Country	Link
US (1)	US20090131469A1 (fr)
EP (1)	EP1852117A4 (fr)
JP (1)	JPWO2006090759A1 (fr)
CA (1)	CA2599158C (fr)
WO (1)	WO2006090759A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008128028A2 (fr) *	2007-04-11	2008-10-23	Dr. Reddy's Laboratories Ltd.	Compositions à base de solifénacine
KR20100040294A (ko) *	2007-07-20	2010-04-19	아스텔라스세이야쿠 가부시키가이샤	전립선 비대에 수반되는 하부 요로 증상의 개선용 의약 조성물
US20100240697A1 (en) *	2007-11-02	2010-09-23	Astellas Pharma Inc.	Pharmaceutical composition for treating overactive bladder
RU2464023C2 (ru) *	2008-05-16	2012-10-20	АКСИС, Инс	Лекарственное средство для лечения фибромиалгии
EP2181707A1 (fr) *	2008-11-04	2010-05-05	Astellas Ireland Co., Ltd.	Utilisation combinée d'un antagoniste de récepteur alpha-adrénergique et d'un agent anti-muscarinique
MX342062B (es) *	2009-02-04	2016-09-12	Astellas Pharma Inc	Composicion farmaceutica para administracion oral.
CN102743757A (zh) *	2012-07-09	2012-10-24	张家华	治疗膀胱流出道梗阻所致膀胱活动过度的药物
WO2022117594A1 (fr)	2020-12-01	2022-06-09	Adamed Pharma S.A.	Préparation administrée par voie orale contenant de la solifénacine et de la tamsulosine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0801067A1 (fr) *	1994-12-28	1997-10-15	Yamanouchi Pharmaceutical Co. Ltd.	Nouveaux derives de quinuclidine et composition pharmaceutique les contenant
US20030191172A1 (en) *	2002-02-19	2003-10-09	Ebrahim Versi	Method of using cyclooxygenase inhibitors and antimuscarinic agents
EP1405638A1 (fr) *	2001-07-10	2004-04-07	Yamanouchi Pharmaceutical Co. Ltd.	Composition medicinale destinee au traitement de la cystite interstitielle

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2000109481A (ja) *	1999-10-13	2000-04-18	Yamanouchi Pharmaceut Co Ltd	キヌクリジン誘導体含有医薬
JP2003267977A (ja) *	2002-03-14	2003-09-25	Yamanouchi Pharmaceut Co Ltd	キヌクリジン誘導体
BR0311414A (pt) *	2002-06-07	2005-03-15	Yamanouchi Pharma Co Ltd	Agente terapêutico para uma bexiga hiperativa
EP1424079A1 (fr) *	2002-11-27	2004-06-02	Boehringer Ingelheim International GmbH	Combinaison d'un agoniste du beta-3-récepteur et d'un inhibiteur de recaptage de sérotonine et/ou norépinéphrine
KR101270908B1 (ko) *	2004-03-25	2013-06-03	아스텔라스세이야쿠 가부시키가이샤	솔리페나신 또는 그의 염의 고형 제제용 조성물
JP3701964B1 (ja) *	2005-03-08	2005-10-05	アステラス製薬株式会社	キヌクリジン誘導体の新規な塩

2006
- 2006-02-23 JP JP2007504758A patent/JPWO2006090759A1/ja active Pending
- 2006-02-23 CA CA2599158A patent/CA2599158C/fr not_active Expired - Fee Related
- 2006-02-23 EP EP06714366A patent/EP1852117A4/fr not_active Withdrawn
- 2006-02-23 WO PCT/JP2006/303226 patent/WO2006090759A1/fr active Application Filing
- 2006-02-23 US US11/817,097 patent/US20090131469A1/en not_active Abandoned

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0801067A1 (fr) *	1994-12-28	1997-10-15	Yamanouchi Pharmaceutical Co. Ltd.	Nouveaux derives de quinuclidine et composition pharmaceutique les contenant
EP1405638A1 (fr) *	2001-07-10	2004-04-07	Yamanouchi Pharmaceutical Co. Ltd.	Composition medicinale destinee au traitement de la cystite interstitielle
US20030191172A1 (en) *	2002-02-19	2003-10-09	Ebrahim Versi	Method of using cyclooxygenase inhibitors and antimuscarinic agents

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; September 2004 (2004-09-01), SMULDERS RONALD A ET AL: "Pharmacokinetics and safety of solifenacin succinate in healthy young men", XP002601457, Database accession no. PREV200400443552 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; April 2004 (2004-04-01), CHILMAN-BLAIR KIM ET AL: "Solifenacin: treatment of overactive bladder.", XP002601458, Database accession no. NLM15190387 *
DRUGS OF TODAY (BARCELONA, SPAIN : 1998) APR 2004 LNKD- PUBMED:15190387, vol. 40, no. 4, April 2004 (2004-04-01), pages 343 - 353, ISSN: 1699-3993 *
JOURNAL OF CLINICAL PHARMACOLOGY, vol. 44, no. 9, September 2004 (2004-09-01), pages 1023 - 1033, ISSN: 0091-2700 *
See also references of WO2006090759A1 *

Also Published As

Publication number	Publication date
CA2599158A1 (fr)	2006-08-31
US20090131469A1 (en)	2009-05-21
EP1852117A1 (fr)	2007-11-07
CA2599158C (fr)	2011-01-25
JPWO2006090759A1 (ja)	2008-07-24
WO2006090759A1 (fr)	2006-08-31

Publication	Publication Date	Title
IL187635A0 (en)	2008-03-20	Amylases for pharmaceutical use
AP2008004533A0 (en)	2008-08-31	Pharmaceutical combination
IL191907A0 (en)	2008-12-29	Azepinoindole derivatives as pharmaceutical agents
PL2175273T3 (pl)	2014-02-28	Środek nadający kokumi
GB0501999D0 (en)	2005-03-09	Pharmaceutical compounds
GB0615545D0 (en)	2006-09-13	Therapeutic agent
GB0419849D0 (en)	2004-10-13	Pharmaceutical combination
IL187510A0 (en)	2008-03-20	Proteases for pharmaceutical use
GB0521139D0 (en)	2005-11-23	Therapeutic agent
EP1852117A4 (fr)	2010-10-27	Agent pharmaceutique comprenant de la solifenacine
EP1927347A4 (fr)	2011-10-12	Agent réducteur d'amertume
EP1889660A4 (fr)	2011-09-21	Agent de decomposition de l'ozone
GB0500643D0 (en)	2005-02-23	Medicaments
EP1871344A4 (fr)	2012-05-02	Medicament inhalable
ZA200804666B (en)	2010-01-27	Pharmaceutical combination
GB0512643D0 (en)	2005-07-27	Pharmaceutical compounds
HK1113463A1 (en)	2008-10-03	Immunopotentiating agent
ZA200710642B (en)	2008-11-26	Proteases for pharmaceutical use
GB0511204D0 (en)	2005-07-06	Medicaments
EP1853258A4 (fr)	2008-05-07	Medicaments
TWI372053B (en)	2012-09-11	Combination drug
GB0508153D0 (en)	2005-06-01	Therapeutic agent
GB0501475D0 (en)	2005-03-02	Pharmaceutical compounds
GB0514530D0 (en)	2005-08-24	Pharmaceutical agent
GB0515315D0 (en)	2005-08-31	Pharmaceutical agents

Legal Events

Date	Code	Title	Description
2007-10-05	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-11-07	17P	Request for examination filed	Effective date: 20070821
2007-11-07	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2008-06-04	DAX	Request for extension of the european patent (deleted)
2010-10-27	A4	Supplementary search report drawn up and despatched	Effective date: 20100929
2010-10-27	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/439 20060101ALI20100921BHEP Ipc: A61P 13/10 20060101ALI20100921BHEP Ipc: A61K 31/4725 20060101AFI20100921BHEP
2011-10-28	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2011-11-30	18D	Application deemed to be withdrawn	Effective date: 20110429